Cargando…
PB2130: RATIONAL FOR METHOTREXATE USAGE FOR THE TREATMENT AND PREVENTION OF CNS INVOLVEMENT IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMAS.
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431466/ http://dx.doi.org/10.1097/01.HS9.0000851352.44937.db |
| _version_ | 1784780063133138944 |
|---|---|
| author | Misyurina, A. Kravchenko, S. Magomedova, A. Kovrigina, A. Obukhova, T. Sychevskaya, K. Babaeva, F. |
| author_facet | Misyurina, A. Kravchenko, S. Magomedova, A. Kovrigina, A. Obukhova, T. Sychevskaya, K. Babaeva, F. |
| author_sort | Misyurina, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431466 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94314662022-08-31 PB2130: RATIONAL FOR METHOTREXATE USAGE FOR THE TREATMENT AND PREVENTION OF CNS INVOLVEMENT IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMAS. Misyurina, A. Kravchenko, S. Magomedova, A. Kovrigina, A. Obukhova, T. Sychevskaya, K. Babaeva, F. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431466/ http://dx.doi.org/10.1097/01.HS9.0000851352.44937.db Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Misyurina, A. Kravchenko, S. Magomedova, A. Kovrigina, A. Obukhova, T. Sychevskaya, K. Babaeva, F. PB2130: RATIONAL FOR METHOTREXATE USAGE FOR THE TREATMENT AND PREVENTION OF CNS INVOLVEMENT IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMAS. |
| title | PB2130: RATIONAL FOR METHOTREXATE USAGE FOR THE TREATMENT AND PREVENTION OF CNS INVOLVEMENT IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMAS. |
| title_full | PB2130: RATIONAL FOR METHOTREXATE USAGE FOR THE TREATMENT AND PREVENTION OF CNS INVOLVEMENT IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMAS. |
| title_fullStr | PB2130: RATIONAL FOR METHOTREXATE USAGE FOR THE TREATMENT AND PREVENTION OF CNS INVOLVEMENT IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMAS. |
| title_full_unstemmed | PB2130: RATIONAL FOR METHOTREXATE USAGE FOR THE TREATMENT AND PREVENTION OF CNS INVOLVEMENT IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMAS. |
| title_short | PB2130: RATIONAL FOR METHOTREXATE USAGE FOR THE TREATMENT AND PREVENTION OF CNS INVOLVEMENT IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMAS. |
| title_sort | pb2130: rational for methotrexate usage for the treatment and prevention of cns involvement in patients with high-grade b-cell lymphomas. |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431466/ http://dx.doi.org/10.1097/01.HS9.0000851352.44937.db |
| work_keys_str_mv | AT misyurinaa pb2130rationalformethotrexateusageforthetreatmentandpreventionofcnsinvolvementinpatientswithhighgradebcelllymphomas AT kravchenkos pb2130rationalformethotrexateusageforthetreatmentandpreventionofcnsinvolvementinpatientswithhighgradebcelllymphomas AT magomedovaa pb2130rationalformethotrexateusageforthetreatmentandpreventionofcnsinvolvementinpatientswithhighgradebcelllymphomas AT kovriginaa pb2130rationalformethotrexateusageforthetreatmentandpreventionofcnsinvolvementinpatientswithhighgradebcelllymphomas AT obukhovat pb2130rationalformethotrexateusageforthetreatmentandpreventionofcnsinvolvementinpatientswithhighgradebcelllymphomas AT sychevskayak pb2130rationalformethotrexateusageforthetreatmentandpreventionofcnsinvolvementinpatientswithhighgradebcelllymphomas AT babaevaf pb2130rationalformethotrexateusageforthetreatmentandpreventionofcnsinvolvementinpatientswithhighgradebcelllymphomas |